´ëÇѽɺÎÀüÇÐȸ µ¿°è ½ÉÆ÷Áö¾ö : 2019-02-16±³À°ÀÏÀÚ : 2019-02-16
±³À°Àå¼Ò : JW¸Þ¸®¾îƮȣÅÚ ¼¿ï 3Ãþ »ì·Õ 4-5
±³À°ÁÖÁ¦ :
´ëÇѽɺÎÀüÇÐȸ µ¿°è ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ¾öÀº¿µ
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ :
khfs@khfs.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-16 »ì·Õ4,5 09:10~09:30 Is a life without RV Possible? (Fontan Procedure) ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 09:30~09:50 RV: Is It More or Less Important than LV ¹ÚÀçÇü(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 09:50~10:10 Severe TR and Severe MR: Similarities and Differences ¹Ú¼ºÁö(¼º±Õ°üÀÇ´ë)
Åä·Ð 02-16 »ì·Õ4,5 10:10~10:30 Discussion ()
ÈÞ½Ä 02-16 »ì·Õ4,6 10:30~11:00 Coffee Break ()
±³À°½Ã°£ 02-16 »ì·Õ4,5 11:00~11:20 Shared Risk Factors of HF and Cancer: Is It Real? Á¶ÇöÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 11:20~11:40 Immune Checkpoint Inhibitor-related Cardiotoxicity Á¶ÁøÇö(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 11:40~12:00 How to Manage Cancer Patients with HF? ±èÀÀÁÖ(°í·ÁÀÇ´ë)
Åä·Ð 02-16 »ì·Õ4,5 12:00~12:20 Discussion ()
½Ä»ç 02-16 »ì·Õ4,5 12:20~13:20 Lunch ()
ÈÞ½Ä 02-16 »ì·Õ4,5 13:20~13:40 Coffee Break ()
±³À°½Ã°£ 02-16 »ì·Õ4,5 13:40~13:55 Lessons from Hemodynamic Cath Lab in Mayo ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,6 13:55~14:10 Ejection Fraction: Where Are You from? À¯º´¼ö(¿øÁÖÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 14:10~14:25 Ejection Fraction Versus Myocardial Strain ÃÖÁø¿À(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 14:25~14:40 Ejection Fraction in HFpEF ÃÖµ¿ÁÖ(¼¿ïÀÇ´ë)
Åä·Ð 02-16 »ì·Õ4,5 14:40~15:00 Discussion ()
±³À°½Ã°£ 02-16 »ì·Õ4,5 15:00~15:15 Case 1 Á¤¹ÌÇâ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 15:15~15:30 Case 2 ±èÇüÀ±(Àü³²ÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 15:30~15:45 Case 3 À̼ö¿ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 02-16 »ì·Õ4,5 15:45~16:00 Case 4 ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë)
Åä·Ð 02-16 16:00~16:20 Discussion ()